Mail

UK markets close in 31 minutes

FTSE 100
8,207.92
+35.77(+0.44%)
FTSE 250
20,180.27
+127.94(+0.64%)
AIM
771.15
+3.04(+0.40%)
GBP/EUR
1.1651
-0.0032(-0.27%)
GBP/USD
1.2545
+0.0012(+0.09%)
Bitcoin GBP
49,128.99
+2,088.50(+4.44%)

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

3.0200

+0.0900

(+3.07%)

As of 10:59AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	433.26M
Enterprise value	185.63M
Trailing P/E	43.96
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.49
Price/book (mrq)	1.40
Enterprise value/revenue	1.09
Enterprise value/EBITDA	-0.98

Trading information

Stock price history

Beta (5Y monthly)	1.24
52-week change ³	-53.86%
S&P500 52-week change ³	22.43%
52-week high ³	9.0800
52-week low ³	2.2800
50-day moving average ³	3.1573
200-day moving average ³	4.6467

Share statistics

Avg vol (3-month) ³	1.72M
Avg vol (10-day) ³	1.68M
Shares outstanding ⁵	147.37M
Implied shares outstanding ⁶	147.37M
Float ⁸	98.38M
% held by insiders ¹	2.79%
% held by institutions ¹	94.13%
Shares short (15 Apr 2024) ⁴	10.01M
Short ratio (15 Apr 2024) ⁴	5.28
Short % of float (15 Apr 2024) ⁴	8.72%
Short % of shares outstanding (15 Apr 2024) ⁴	6.79%
Shares short (prior month 15 Mar 2024) ⁴	8.46M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-132.28%
Operating margin (ttm)	-99.68%

Management effectiveness

Return on assets (ttm)	-16.60%
Return on equity (ttm)	-58.34%

Income statement

Revenue (ttm)	170.28M
Revenue per share (ttm)	1.18
Quarterly revenue growth (yoy)	-17.10%
Gross profit (ttm)	N/A
EBITDA	-179.38M
Net income avi to common (ttm)	-225.25M
Diluted EPS (ttm)	-1.5600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	346.4M
Total cash per share (mrq)	2.39
Total debt (mrq)	229.43M
Total debt/equity (mrq)	74.42%
Current ratio (mrq)	4.66
Book value per share (mrq)	2.13

Cash flow statement

Operating cash flow (ttm)	-156.32M
Levered free cash flow (ttm)	-81.95M